BKGI closed the first day of trading at 4.40 baht, 169.94% higher than its IPO price.

HoonSmart.com>>BKGI shares closed the first day of trading at 4.40 baht, 169.94% higher than the IPO price. Krungsri Patanasin Securities exclaimed “buy”, highlighting 4 points of interest: 1. Advantage in technology 2. Laboratory capable of supporting growth continuously 3. Providing screening services for all age groups 4. Financial situation is stable

BKGI shares closed the first day of trading at 4.40 baht, an increase of 2.77 baht or +169.94% from the IPO selling price of 1.63 baht per share, trading value of 3,227.88 million baht, with the market opening at 2.18 baht, the highest of 4.40 baht. The lowest is 2.14 baht.

Krungsri Patanasin Securities recommends a “buy” on Bangkok Genomics Innovation Company (BKGI) shares, with fundamental value in 2024 estimated at 2.50 baht per share using the DCF method, WACC of 9.2%, and LT growth of 3%. , and is calculated into a PE multiple in 2024 of 29.4 times, higher than the average 3-year PE of 26.3 times in the medical sector. BKGI is interesting 1) It has technological advantages. It has received many knowledge transfers from the BGI Group, which is a major contributor and innovator in genomics. 2) The laboratory has the ability to support continued growth. 3) Providing screening services for all age groups. This creates an opportunity for growth through expanding the open customer base and 4) a stable financial position. No financial institution debts